S See

Summary

Affiliation: St. John's University
Country: USA

Publications

  1. ncbi request reprint Candesartan cilexetil: an angiotensin II-receptor blocker
    S See
    Department of Clinical Pharmacy Practice, College of Pharmacy and Allied Health Professions, St John s University SJU, Jamaica, NY 11439, USA
    Am J Health Syst Pharm 57:739-46. 2000
  2. ncbi request reprint Angiotensin II receptor blockers for the treatment of hypertension
    S See
    St John s University College of Pharmacy, 8000 Utopia Parkway, NY 11439, USA
    Expert Opin Pharmacother 2:1795-804. 2001
  3. ncbi request reprint Penicillin-induced Jarisch-Herxheimer reaction
    Sharon See
    College of Pharmacy and Allied Health Professions, St John s University, Queens, NY 11439, USA
    Ann Pharmacother 39:2128-30. 2005
  4. doi request reprint Skeletal muscle relaxants
    Sharon See
    Clinical Pharmacy Practice Department, St John s University College of Pharmacy and Allied Health Professions, Queens, New York, NY 11439, USA
    Pharmacotherapy 28:207-13. 2008
  5. ncbi request reprint Choosing a skeletal muscle relaxant
    Sharon See
    St John s University College of Pharmacy and Allied Health Professions, Jamaica, New York 11439, USA
    Am Fam Physician 78:365-70. 2008
  6. doi request reprint Akathisia induced by gabapentin withdrawal
    Sharon See
    St John s University College of Pharmacy and Allied Health Professions, Jamaica, NY, USA
    Ann Pharmacother 45:e31. 2011
  7. ncbi request reprint Exenatide: a novel incretin mimetic agent for treating type 2 diabetes mellitus
    Sum Lam
    Department of Clinical Pharmacy Practice, College of Pharmacy and Allied Health Professions, St John s University, Jamaica, New York 11439, USA
    Cardiol Rev 14:205-11. 2006

Detail Information

Publications7

  1. ncbi request reprint Candesartan cilexetil: an angiotensin II-receptor blocker
    S See
    Department of Clinical Pharmacy Practice, College of Pharmacy and Allied Health Professions, St John s University SJU, Jamaica, NY 11439, USA
    Am J Health Syst Pharm 57:739-46. 2000
    ..It is generally well tolerated and may be an option for patients who cannot tolerate angiotensin-converting-enzyme inhibitors because of cough...
  2. ncbi request reprint Angiotensin II receptor blockers for the treatment of hypertension
    S See
    St John s University College of Pharmacy, 8000 Utopia Parkway, NY 11439, USA
    Expert Opin Pharmacother 2:1795-804. 2001
    ..This article reviews the differences among the ARBs, existing efficacy data in hypertension, and explores the role of ARBs in CHF and renal disease...
  3. ncbi request reprint Penicillin-induced Jarisch-Herxheimer reaction
    Sharon See
    College of Pharmacy and Allied Health Professions, St John s University, Queens, NY 11439, USA
    Ann Pharmacother 39:2128-30. 2005
    ..To report a case of Jarisch-Herxheimer reaction (JHR) in a patient with presumed neurosyphilis and HIV...
  4. doi request reprint Skeletal muscle relaxants
    Sharon See
    Clinical Pharmacy Practice Department, St John s University College of Pharmacy and Allied Health Professions, Queens, New York, NY 11439, USA
    Pharmacotherapy 28:207-13. 2008
    ..Therefore, the choice of a skeletal muscle relaxant should be based on its adverse-effect profile, tolerability, and cost...
  5. ncbi request reprint Choosing a skeletal muscle relaxant
    Sharon See
    St John s University College of Pharmacy and Allied Health Professions, Jamaica, New York 11439, USA
    Am Fam Physician 78:365-70. 2008
    ..Because of limited comparable effectiveness data, choice of agent should be based on side-effect profile, patient preference, abuse potential, and possible drug interactions...
  6. doi request reprint Akathisia induced by gabapentin withdrawal
    Sharon See
    St John s University College of Pharmacy and Allied Health Professions, Jamaica, NY, USA
    Ann Pharmacother 45:e31. 2011
    ..To report a case of akathisia in a patient with type 2 diabetes after abrupt discontinuation of gabapentin...
  7. ncbi request reprint Exenatide: a novel incretin mimetic agent for treating type 2 diabetes mellitus
    Sum Lam
    Department of Clinical Pharmacy Practice, College of Pharmacy and Allied Health Professions, St John s University, Jamaica, New York 11439, USA
    Cardiol Rev 14:205-11. 2006
    ..It is also an alternative therapy for those patients who cannot tolerate other antidiabetic drugs...